After More Than 30 Years of Service, Management Board Member Caroll H. Neubauer Retires from B. Braun
Dr. Jean-Claude Dubacher Appointed Chairman and Chief Executive Officer of B. Braun of America Inc.
BETHLEHEM, PA – June 5, 2020 – The Supervisory Board of B. Braun SE today announced that Caroll H. Neubauer will retire at the end of August 2020 after thirty-two years of distinguished service to B. Braun, including twenty-nine years serving on the Management Board of the B. Braun Group.
Neubauer began his career with B. Braun in 1988 as Legal Assistant to the Chairman of the Management Board, and in 1991 was appointed to the Management Board and as General Counsel for the B. Braun Group. Neubauer led B. Braun’s operations in North America since 1996, overseeing the organization’s steady growth from $247 million in annual revenue to more than $2 billion with over 8,000 employees in 2019. B. Braun of America Inc. is headquartered in Bethlehem, Pennsylvania and includes B. Braun Medical Inc., B. Braun Interventional Systems, Aesculap® and Central Admixture Pharmacy Services Inc. (CAPS®).
“We thank Caroll Neubauer for more than three decades of truly remarkable achievements for our company, for his close collaboration with our partners in the healthcare industry, and for his tireless work for the benefit of patients and healthcare providers," said Prof. Ludwig Georg Braun, Chairman of the Supervisory Board of B. Braun SE. “Unforgotten will remain as well his persistent, determined and successful efforts to achieve the repeal of the US Medical Device Tax.”
Anna Maria Braun, Chief Executive Officer of B. Braun SE and B. Braun Melsungen AG praised his exceptional commitment: “We thank Caroll for his pioneering leadership, his valuable advice, his passionate support for our employees and, above all, for his friendship."
On June 1, 2020, Dr. Jean-Claude Dubacher succeeded Neubauer as Chairman and Chief Executive Officer of B. Braun of America Inc. Neubauer will continue as a Member of the Management Board of B. Braun SE and Executive Director of B. Braun of America Inc. until August 31, 2020. Dr. Dubacher joined B. Braun in August 2019 as President, B. Braun Medical Inc., and became Chairman and Chief Executive Officer of B. Braun Medical Inc. on January 1, 2020.
“Caroll Neubauer has done everything to ensure a smooth transition of leadership,” continued Anna Maria Braun. “Thanks to his efforts, we are well positioned to continue strong growth in North America. Under Jean-Claude Dubacher’s leadership moving forward, I am confident the future of B. Braun of America Inc. is bright.”
About B. Braun
B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. Other key product areas include nutrition, pharmacy admixture and dialysis. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is headquartered in Bethlehem, PA and is part of the
B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap® and CAPS®.
Globally, the B. Braun Group of Companies employs more than 64,000 employees in 64 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, explore our website.